SRPT PEER ANALYSIS

Sarepta Therapeutics Inc — metric-by-metric comparison with peers and the industry median

SRPTSarepta Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

SRPTIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	SRPT	TLX	MSB	CSL	Ind. Median
P/E	36.13	—	—	29.44●	17.91
P/B	1.56●	6.37	—	2.20	3.51
EV/EBITDA	21.88	120.14	—	10.21●	14.82
P/S	1.08●	3.24	31.61	2.62	10.89

Financial Health
Metric	SRPT	TLX	MSB	CSL	Ind. Median
Current Ratio	4.63●	1.43	—	2.57	5.90
Debt/Equity	68.9%	112.3%	—	67.4%●	10.9%
NetDebt/EBITDA	3.07	13.13	—	2.22●	1.15

Profitability
Metric	SRPT	TLX	MSB	CSL	Ind. Median
Net Margin	3.0%	-0.9%	-115.3%	9.2%●	-125.7%
ROE	4.9%	-1.8%	-11.3%	7.7%●	-47.5%
ROA	2.0%	-0.7%	-8.6%	3.8%●	-35.8%
EBITDA Margin	5.7%	3.0%	-76.6%	32.8%●	-105.8%

Growth + Dividend
Metric	SRPT	TLX	MSB	CSL	Ind. Median
Rev. Growth	-2.2%	56.3%	410.4%●	4.8%	5.1%
NI Growth	—	—	—	-39.4%	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.2%
Payout	—	—	0.0%	103.1%	0.0%

Valuation
Metric	SRPT	BHVN	KOD	VCEL	MLYS	AGIO	Ind. Median
P/E	36.13●	—	—	111.14	—	—	17.91
P/B	1.56●	18.19	21.27	6.70	3.59	1.99	3.51
EV/EBITDA	21.88●	—	—	66.21	—	—	14.82
P/S	1.08●	—	—	8.17	—	33.45	10.89

Financial Health
Metric	SRPT	BHVN	KOD	VCEL	MLYS	AGIO	Ind. Median
Current Ratio	4.63	7.41	3.54	5.18	44.33●	14.19	5.90
Debt/Equity	68.9%	221.0%	139.2%	26.5%	—	3.2%●	10.9%
NetDebt/EBITDA	3.07	0.10	0.07	-1.44●	—	1.68	1.15

Profitability
Metric	SRPT	BHVN	KOD	VCEL	MLYS	AGIO	Ind. Median
Net Margin	3.0%	—	—	7.3%●	—	-639.8%	-125.7%
ROE	4.9%	-333.0%	-208.8%	6.6%●	-31.0%	-32.8%	-47.5%
ROA	2.0%	-140.0%	-76.4%	4.7%●	-30.1%	-30.8%	-35.8%
EBITDA Margin	5.7%	—	—	12.1%●	—	-633.4%	-105.8%

Growth + Dividend
Metric	SRPT	BHVN	KOD	VCEL	MLYS	AGIO	Ind. Median
Rev. Growth	-2.2%	-100.0%	-100.0%	22.4%	-100.0%	78.3%●	5.1%
NI Growth	—	—	—	620.7%	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on SRPT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.